STI-001（Stimunity）

N/A

Report date: 2023/01/04 20:07:40

Base Information

Drug NameSTI-001（Stimunity）
Drug Alias NamecGAMP-VLP STI-001（Stimunity）STI-001（Stimunity）
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionStimulator of interferon genes stimulants
TargetsStimulator of interferon genes
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStimunity SAS
China Registration ClassN/A

Develop Information

Active CompaniesStimunity SAS
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A